- About bilaterals.org
- How to participate
- Key issues
- Texts of agreements
Ranbaxy deal may help India’s entry into Japan
Financial Express | June 14, 2008
Ranbaxy deal may help India’s entry into Japan
New Delhi, Jun 13 — The Daiichi Sankyo-Ranbaxy Laboratories deal has come as a shot in the arm for India’s Comprehensive Economic Co-operation Agreement (CECA) negotiations with Japan. Indian pharma companies have been unable to break into Japan, the world’s second largest drug market, due to the country’s stringent sanitary and phytosanitary standards, technical barriers to trade (TBT) and environmental norms.
"The acquisition of Ranbaxy is arecognition of the quality of Indian drug and other pharma products bytheir Japanese counterparts. Before signing the CECA (Comprehensive Economic Cooperation Agreement), we will now aggressively push the case of our pharma sector as well as that of the chemicals, bio-tech and cosmetics sectors to ensure that Japan agrees to opening up their market for these products," a government official told FE.
Since the current Japanese standards on drugs and other pharmaceuticals products are higher than the accepted international standards, it amounts to a non-tariff barrier, the officialofficial added. India will ask Japan to bring their national standards to international levels and also ensure that there is a harmonization of SPS and TBT standards of both countries.
The government is, however, seeing the Ranbaxy deal as a bigger opportunity apart from getting a foothold in the $65 billion pharma market. In a bid to pave the way for the entry of Indian health industry into Japan, New Delhi would also pitch for relaxing the norms for movement of doctors, nurse and other health professionals from India to Japan.
Indian industry sees Japan’s drug approval procedures as stricter and time-consuming. Besides, it is also mandatory to get such products are tested in Japan itself as they do not accept products tested outside that country.
India would now demand that if the US FDA (Food and Drug Administration) has given approval to a drug, Japan must also allow it without any further testing. The government is also keeping a close watch on the deal’s impact on the Indian pharma market and if it would result in costlier drugs entering the country.
Please join the more than 1.7 million people who have signed the European Citizen’s Initiative to stop TTIP and CETA. Help us reach the 2 million mark! https://stop-ttip.org/sign/
News from the movements
26-May-2015 New InternationalistIn a series of forthcoming votes, the European Parliament and US Congress are turning their attention to an agreement that is becoming more toxic with every passing day.
25-May-2015 NO 2 ISDS!Join this e-action on the European Parliament, asking MEPs to pledge that they will reject ISDS in TTIP. The action is going to run until the vote in the plenary on 10 June and is available in 9 languages.
25-May-2015 The EcologistIn the rush to oppose TTIP we mustn’t lose sight of the context in which the deal is being negotiated — the hundreds of bilateral treaties that give corporations the right to sue in secret ’trade courts’.
22-May-2015 Amigos de la TierraOrganizaciones lanzan una ciberacción para reclamar a los europarlamentarios que apuesten por la gente.
15-May-2015 Cumbre de los Pueblos 2015
Días de Movilización. Por la soberanía de los pueblos frente al poder de las transnacionales y la arquitectura de tratados de comercio e inversionesLes invitamos a un evento público de Lanzamiento de los Días de Movilización el 8 de junio, seguido de actividades de movilización el 9 y 10 de junio en las Maison des Associations en Bruselas.
15-May-2015 Jacobin MagazineOpponents of the trade deal being secretly negotiated between the United States, Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, and Vietnam have moved the discussion beyond its putative impact on jobs and growth and closer to the agreement’s broader ramifications, writes the IUF’s Peter Rossman.
13-May-2015 teleSUROn Monday, a coalition of Peruvian civil society organizations issued a strong warning as negotiations for the Trans Pacific Partnership treaty (TPP) come to an end.
13-May-2015 Common DreamsIn what was immediately heralded as a victory for the grassroots, Senate Democrats on Tuesday stymied President Barack Obama’s corporate-driven trade agenda by voting to prevent the chamber from taking up Fast Track legislation.
bilaterals.org is a collaborative space to share information and support movements struggling against bilateral trade and investment deals which serve corporations, not people. Multilingual. Global. No one owns it. Open publishing. Join us.